Statistics
Publications
7
Citations
266
H-Index
7
Active since
2004
Brian T. Kalet is an author at University of Colorado Boulder specializing in cancer pharmacology, chemotherapy, and pharmacology.
Publications per year
2004–2013
7
7
Doxorubicin-formaldehyde conjugates targeting alphavbeta3 integrin.
David J. Burkhart, Brian T. Kalet, Michael P. Coleman et al. · PubMed · 2004 · 69 citations
Doxorubicin-formaldehyde conjugates targeting αvβ3 integrin
David J. Burkhart, Brian T. Kalet, Michael P. Coleman et al. · Molecular Cancer Therapeutics · 2004 · 64 citations · Full text
1–5 of 7